The primary endpoints for the PERSEUS, MAIA and CEPHEUS trials
What is PFS for PERSEUS & MAIA, MRD negativity rate for CEPHEUS?
Approximately this number of letters have been sent by MM patients and caregivers to government and healthcare organizations to advocate for the importance of CARVYKTI access in Canada
What is >5600?
The number of patients treated worldwide by TECVAYLI
What is >22,000 patients?
What are blue, yellow, black, green, and red?
The movie this famous line is from (cue Alex)
What is Home Alone?
The definition of "not candidates for transplant" for the CEPHEUS indictation.
What is <70 years transplant ineligible, or <70 and refusal to transplant [meaning was not planned as initial therapy], ≥70 years?
CARVYKTI received a LOE from the pCPA on this date
What is February 6th, 2026?
The key commercial execution step if an HCP is interested in prescribing TECVAYLI and/or TALVEY for the first time
What is the Risk Management Tool rep-triggered e-mail?
The sport making its Olympic debut at the 2026 Winter Games
What is Ski Mountaineering?
The two access goals for Talvey in 2026
What are (1) what are positive CDA recommendation with modified criteria (2) Negotiate for Quebec with pCPA in a manner compatible with a subsequent TAL-1 negotiation for ROC
The MRD negativity rate for CEPHEUS at the 58.7mo follow-up
What is 60.9% for D-VRd vs 39.4% for VRd?
This efficacy outcome is considered the single greatest driver of HCP treatment choice for RRMM
What is associated with an OS benefit?
IWMG Sequencing recommendations for anti-BCMA therapies
What is CART, then bispecifics, then antibody drug conjugates (ADC or Blenrep)?
The number of Canadian athletes at the 2026 Winter Games (same number as in 2010!)
What is 206?
What is 30%?
What is: (1) route of administration (2) patient preference (3) less frequent dosing schedule (4) familiarity with regimen?
According to both patients and HCPs, this remains the greatest barrier to CAR-T referral in Canada (not access!!)
What is logistical complexity (travel and accommodation)?
Either (a) does not have a pathway to offer TEC (b) has a pathway that may be limited by capacity in the future (c) has a competitive risk
The Canadian flag bearers at the 2026 Winter Olympic Games
Who are Mikaël Kingsbury and Marielle Thompson,?
The reduction in injections between MAIA and IMROZ or CEPHEUS and IMROZ in the first 1 year of treatment?
What is 5 less injections using MAIA vs IMROZ or 9 less injections using CEPHEUS vs IMROZ?
The key message we will deliver to HCPs regarding the meaningful OS improvement demonstrated by CARVYKTI in the 33-month follow-up data
What is CARVYKTI, a one-time infusion, is the first and only cell therapy to demonstrate a statistically significant and clinically meaningful improvement in OS vs. the SoC (DPd or PVd) in len-ref MM patients as early as first relapse?
The overall response rate of TECVAYLI at 29.5 months AND the number of responders who achieved complete response or better
What is 62.4% ORR and 7 in 10 responders achieved CR or better?
Location of the 2028 Summer and 2030 Winter Olympics
What are Los Angeles and French Alps?
New Patient share target for DARZALEX Front-line newly diagnosed Multiple myeloma
What is >84%?